After 3.5 years of follow-up, there was a 98% rate of minimal residual disease, and 9 patients were still in complete remission.

Eddie Kaufman, a sophomore at Roanoke College, was living out his dream on the baseball diamond until life threw him a ...

Fugitive businessman Mehul Choksi battles chronic lymphocytic leukemia while facing extradition from Belgium Learn all about ...

Roanoke College will hold a bone marrow donor registry drive to support one of its students who has leukemia and is in need of a blood stem cell transplant.

Allogene Therapeutics, Inc.’s ALLO share price has surged by 6.64%, which has investors questioning if this is right time to ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Briar Jones will continue his chemotherapy treatments in Atlanta and if everything continues to go well, he can enroll in daycare this fall.

The 10-year-old Northwood Elementary School fourth-grader eases into his chair, takes some bites of the meal and intently listens as his mother, Erin, describes her son’s journey over the past two ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

Although CD19-directed CAR T cells can initially induce remission in 70-90% of patients with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL), post-CAR relapses are frequent. These ...

As Jake Paskell walked into his team's dugout, the Quinsigamond freshman was presented with a T-shirt that says: In this ...

FOX23 recently visited St. Jude Children's Research Hospital in Memphis to meet patient families and staff and learned what ...